Lineage Cell Therapeutics, Inc. (LCTX) vs Prelude Therapeutics Incorporated (PRLD)
- Lineage Cell Therapeutics, Inc. LCTX 0.98 −1.01%
- Prelude Therapeutics Incorporated PRLD 3.26 −1.81%
Lineage Cell Therapeutics, Inc. and Prelude Therapeutics Incorporated are both Biotechnology companies. Lineage Cell Therapeutics, Inc. and Prelude Therapeutics Incorporated are of similar size ($265.0M and $250.5M). Lineage Cell Therapeutics, Inc. has the higher net margin (−246.6% vs −269.8%) and the lower return on invested capital (−186.8% vs 0.00%). Across the 16 metrics below, Prelude Therapeutics Incorporated leads on 10 and Lineage Cell Therapeutics, Inc. on 6.
Valuation
Profitability
| Metric | LCTX | PRLD | Biotechnology median |
|---|---|---|---|
| Gross margin | 99.46% | 100.00% | 65.16% |
| Operating margin | (205.23%) | (300.56%) | 0.00% |
| Net margin | (246.58%) | (269.75%) | 0.00% |
| Free cash flow margin | (186.43%) | (148.30%) | 0.00% |
| Return on equity | (60.35%) | (57.73%) | (56.36%) |
| Return on assets | (32.75%) | (39.76%) | (48.04%) |
| Return on invested capital | (186.79%) | 0.00% | 0.00% |
Growth
Health
Dividend
Size
Any metric, up to five companies and an Excel export Powerpack